-
Half-year medical commercial bribery cases will be notified and included in the credit rating of pharmaceutical companies
Time of Update: 2021-06-04
The National Medical Insurance Administration’s "Notice on Accelerating the Implementation of the Medical Price and Recruitment Credit Evaluation System" clearly mentioned "In accordance with the territorial principle, all provincial-level centralized procurement agencies pay close attention to the judgment documents and administrative penalty decisions published by the courts, taxation, market supervision and other departments of the region, especially the typical cases reported by the media, and promptly inquire and investigate the enterprises involved.
-
Guangdong: Taking multiple measures simultaneously to carry out the publicity and implementation activities of the newly revised "Regulations on the Supervision and Administration of Medical Devices"
Time of Update: 2021-06-04
Regulations and regulations The market supervision bureaus in Zhuhai, Foshan, Jiangmen, Heyuan, Zhaoqing and other places have also carried out various forms of new "Regulations" publicity and implementation training, setting off a new round of enthusiasm for learning the new "Regulations.
-
The U.S. FDA approves an innovative oral compound drug for the treatment of schizophrenia and bipolar I disorder
Time of Update: 2021-06-04
On June 1, 2021, Alkermes announced that the US FDA has approved its new drug Lybalvi (formerly known as ALKS 3831) for the treatment of adult schizophrenia and bipolar I disorder.
-
WHO puts China's Kexing Covid-19 vaccine on the "emergency use list"
Time of Update: 2021-06-04
WHO puts China's Kexing Covid-19 vaccine on the "emergency use list" WHO puts China's Kexing Covid-19 vaccine on the "Emergency Use List" WHO puts China's Kexing Covid-19 vaccine on
-
Ten thousand mu of honeysuckle in Xinjiang enters the picking season, special industries help rural revitalization
Time of Update: 2021-06-04
(Finish)Herbs medicinal herbs At present, the 20,000 mu of honeysuckle planted in Yuepuhu County, Xinjiang, on the edge of the Taklimakan Desert is in the picking season.
-
Zhejiang pharmaceutical company enters 3 billion injections!
Time of Update: 2021-06-04
Recently, the official website of the State Food and Drug Administration showed that Zhejiang Zuoli Pharmaceutical's esomeprazole sodium for injection was approved for production of imitation 6 categories.
-
Hengrui Medicine: Caspofungin Acetate for Injection passed the consistency evaluation of generic drugs
Time of Update: 2021-06-04
On May 31, Hengrui Medicine stated that it had recently received the "Drug Supplementary Application Approval Notice" on caspofungin acetate for injection approved and issued by the National Medical Products Administration.
The company's caspofungin acetate for injection passed the generic drug Consistency evaluation of quality and efficacy.
-
Chinese medicine concept stocks fly together in May, and the Chinese herbal medicine market continues to be hot!
Time of Update: 2021-06-04
Second, a brief analysis of falling varieties Table 1: Top 25 varieties that fell in April 2021 Patchouli has a new beginning, and the production area and market holders are actively selling.
-
Inheriting the essence, keeping integrity and innovation-Liu Qingquan, one of the series of reports on the anti-epidemic report of TCM: Let the development of TCM enter a new era
Time of Update: 2021-06-04
” In conjunction with the treatment of the new crown epidemic, Liu Qingquan, Dean of Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, said when talking about his experience, the integration of Chinese and Western medicine is very important for the development of Chinese medicine, and it may be possible in the future.
-
Scholars from many countries believe that laboratory leaks conspiracy theories undermine global anti-epidemic efforts
Time of Update: 2021-06-04
A recent report in The Wall Street Journal cited so-called "intelligence" that three scientific researchers from Wuhan Institute of Virology were hospitalized with a serious illness in November 2019, with "symptoms consistent with the new crown infection and common seasonal diseases.
-
Microchip Bio: Sigglita Sodium Tablets Obtained Clinical Trial Notice
Time of Update: 2021-06-04
This is the company’s application for Siglie An important basis for the treatment of non-alcoholic fatty liver with sodium.
-
Wanchun Pharmaceutical's U.S. listing application for pranabulin was granted priority review by FDA
Time of Update: 2021-06-04
Article source: Medical Rubik's Cube InfoOn June 1, Wanchun Medicine announced that its core product "Punablin Concentrate Solution for Injection" for use in chemotherapy-induced severe neutropenia (CIN) for new drug listing applications (NDA) has been officially accepted by the US FDA , And obtained the priority review qualification granted by the FDA.
-
How does Merck do well in the "solver" of China's pharmaceutical technology problems behind the production of Taibang's blood products
Time of Update: 2021-06-04
It is worth noting that in addition to the production process solutions of Taibang Bio-Blood Products, Merck has been playing an increasingly important role in the innovation and development of China's biomedicine in the decades since entering the Chinese market.
-
World Multiple Sclerosis Day Disease Science Popularization Event Held
Time of Update: 2021-06-04
Professor Jiao Yujuan of the Department of Neurology of the China-Japan Friendship Hospital said: “Although the current treatments cannot completely cure multiple sclerosis, there are several highly effective disease-correcting drugs in China that can prevent the recurrence of the disease and delay the progression of disability.
-
Zhao Yuliang: Progress of smart nanomachines used in the treatment of major diseases
Time of Update: 2021-06-04
Smart nanomachines provide the possibility to solve this challenge: an ideal nanomedicine carrier should be able to circulate in the body for a long time, reach the lesion area spontaneously or under guidance, accurately identify disease-specific markers on cells or pathogens, and target different pathological environments Release the corresponding reporter molecules and drugs, which we vividly call "nano robots".
-
The picture shows the new crown vaccine: How to protect against the Dragon Boat Festival?
Time of Update: 2021-06-04
In case of sudden major changes, Zhang Yuntao mentioned that the development of vaccines in my country will be very timely and can also meet the needs of the broad masses of people under the conditions of mutations.
-
The fifth batch of centralized procurement of these pharmaceutical companies entered
Time of Update: 2021-06-04
Pay equal attention to price and qualityOn May 8th, Shanghai Sunshine Pharmaceutical Procurement Network announced that the fifth batch of state-organized centralized drug procurement related information declaration work will be launched from May 10th.
-
Implementation of the "Regulations on the Supervision and Administration of Medical Devices" related matters
Time of Update: 2021-06-04
Regarding the production license and record management of medical devices Before the release and implementation of relevant regulations on production licenses and filings supporting the new "Regulations," medical device registrants and filing persons handle production licenses, filing and commissioned production in accordance with existing regulations and normative documents.
-
The first KRAS inhibitor received accelerated approval, non-pharmacological targets, counterattack multiple drugs on the road
Time of Update: 2021-06-04
On May 28, 2021, the FDA announced the accelerated approval of the KRAS inhibitor Lumakras (sotorasib, AMG510) [1] for the treatment of non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations.
-
Full coverage of the purchase of coronary balloon belts during the year!
Time of Update: 2021-06-04
Figure: A summary of the distribution and decline of the volume of coronary balloons purchased in various provinces (cities, districts) across the country Medical News, June 1st, May 26, 2021), Shanghai Sunshine Medical Purchasing Network published the "Notice on Carrying out Shanghai Municipality's Centralized Procurement of Coronary Balloon Medical Consumables".
